l-carnitine tmao nature medicine 2013 koeth

l-carnitine tmao nature medicine 2013 koeth Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis γ–Butyrobetaine is a pro-atherogenic intermediate

Name: l-carnitine tmao nature medicine 2013 koeth Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis γ–Butyrobetaine is a pro-atherogenic intermediate
Brand: www.ohotnichi-sezoni.com
SKU: 3936237940
Price: 23.42 USD
Availability: InStock
Rating: 4.4293000000000005 (26 reviews)

Butyrobetaine is a pro atherogenic intermediate in gut microbial metabolism of L carnitine to TMAO PMC The microbial metabolite trimethylamine N oxide promotes antitumor immunity in triple negative breast cancer: Cell Metabolism Trimethylamine Noxide: breathe new life Subramaniam 2018 British Journal of Pharmacology Wiley Online Library Innovative carnitine fed rats model reveals resveratrol butyrate Ester's multimechanistic role in reducing TMAO and cardiovascular risk ScienceDirect A systematic review of TMAO, microRNAs, and the oral gut microbiomes in atherosclerosis and myocardial infarction: mechanistic insights and translational opportunities Journal of Translational Medicine Springer Nature Link

SKU: 3936237940 · From www.ohotnichi-sezoni.com

4.4

USD23.42 USD46.42

Pay in 4 interest-free payments of $5.86 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

2022;8:eabm9427

[DOI] [PubMed] [Google Scholar] 65.Dhingra D., Joshi P., Gupta A., Chhillar R

Hepatic steatosis can result from impaired lipid handling, including increased lipid uptake, altered synthesis and secretion of hepatic lipids or disrupted -oxidation